BR0108096A - Método para manter ou melhorar a sìntese de mucinas - Google Patents

Método para manter ou melhorar a sìntese de mucinas

Info

Publication number
BR0108096A
BR0108096A BR0108096-2A BR0108096A BR0108096A BR 0108096 A BR0108096 A BR 0108096A BR 0108096 A BR0108096 A BR 0108096A BR 0108096 A BR0108096 A BR 0108096A
Authority
BR
Brazil
Prior art keywords
maintaining
improving
synthesis
mucin
disease states
Prior art date
Application number
BR0108096-2A
Other languages
English (en)
Other versions
BRPI0108096B1 (pt
Inventor
Olivier Ballevre
Paul-Andre Finot
Denis Breuille
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27052980&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0108096(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/774,814 external-priority patent/US6833350B2/en
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of BR0108096A publication Critical patent/BR0108096A/pt
Publication of BRPI0108096B1 publication Critical patent/BRPI0108096B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"MéTODO PARA MANTER OU MELHORAR A SìNTESE DE MUCINAS". Métodos para manter, melhorar ou aumentar a síntese de mucina administrando-se um suplemento ou composição nutricional que contém uma quantidade terapeuticamente eficaz de treonina são fornecidos. A presente invenção ainda fornece métodos para tratar diversos estados de doença caracterizados pelas alterações dos níveis de mucina, tal como, infecções bacterianas e inflamatórias intestinais ou outros tipos de estados de doença.
BRPI0108096A 2000-02-04 2001-01-31 usos de uma fonte de proteína compreendendo aminoácidos em que o teor de treonina é de pelo menos 5,5% em peso dos aminoácidos BRPI0108096B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49890500A 2000-02-04 2000-02-04
US09/774,814 US6833350B2 (en) 2000-02-04 2001-01-30 Method for maintaining or improving the synthesis of mucins
PCT/EP2001/001013 WO2001056405A2 (en) 2000-02-04 2001-01-31 A method for maintaining or improving the synthesis of mucins

Publications (2)

Publication Number Publication Date
BR0108096A true BR0108096A (pt) 2002-10-29
BRPI0108096B1 BRPI0108096B1 (pt) 2017-05-09

Family

ID=27052980

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0108096A BRPI0108096B1 (pt) 2000-02-04 2001-01-31 usos de uma fonte de proteína compreendendo aminoácidos em que o teor de treonina é de pelo menos 5,5% em peso dos aminoácidos

Country Status (22)

Country Link
EP (1) EP1255452B2 (pt)
JP (1) JP2003533436A (pt)
CN (1) CN1434681B (pt)
AT (1) ATE323422T1 (pt)
AU (1) AU784137B2 (pt)
BG (1) BG106967A (pt)
BR (1) BRPI0108096B1 (pt)
CA (1) CA2399063C (pt)
CZ (1) CZ20022978A3 (pt)
DE (1) DE60118888T3 (pt)
DZ (1) DZ3298A1 (pt)
ES (1) ES2261383T5 (pt)
HR (1) HRP20020647A2 (pt)
HU (1) HUP0204439A3 (pt)
IL (1) IL150977A (pt)
MA (1) MA25656A1 (pt)
MX (1) MXPA02007491A (pt)
NO (1) NO20023640L (pt)
NZ (1) NZ520605A (pt)
PL (1) PL357078A1 (pt)
SK (1) SK11212002A3 (pt)
WO (1) WO2001056405A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2382874A1 (en) 2003-06-23 2011-11-02 Nestec S.A. Amino acid supplementation for a healthy microbiota ecosystem
WO2007004613A1 (ja) 2005-07-01 2007-01-11 Ajinomoto Co., Inc. 炎症性腸疾患治療薬及びＴＮＦ－α産生抑制剤
CA2631220A1 (en) * 2006-01-09 2007-07-19 Nestec S.A. Treatment of stressed patients
WO2012133198A1 (ja) * 2011-03-25 2012-10-04 イーエヌ大塚製薬株式会社 炎症性疾患用栄養組成物
CN103813796A (zh) 2011-07-22 2014-05-21 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道修复的低聚半乳糖
EP3167895A1 (en) * 2015-11-10 2017-05-17 University College Dublin A dietary supplement comprising beta-glucan and casein hydrolysate for improving health and growth performance in a mammal

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459620B1 (fr) * 1979-06-26 1983-08-05 Agronomique Inst Nat Rech Hydrolisat enzymatique total de proteines de lactoserum, obtention et application
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤
CA1338682C (en) * 1988-12-23 1996-10-29 Gustavo Bounous Biologically active undenatured whey protein concentrate as food supplement
JP2805490B2 (ja) * 1989-02-07 1998-09-30 雪印乳業株式会社 細菌毒素中和剤
JP3007694B2 (ja) * 1990-12-14 2000-02-07 雪印乳業株式会社 胃潰瘍予防または治療のための医薬及び飲食品
DE69331528T2 (de) * 1992-12-23 2002-10-31 Abbott Laboratories, Abbott Park Medizinische nahrungsmittel für die ernährungsergänzung bei metabolischen erkrankungen von säuglingen/kleinkindern
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
FR2711529B1 (fr) * 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
JPH07267855A (ja) * 1994-03-30 1995-10-17 Taiho Yakuhin Kogyo Kk グルタミン産生剤
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
US5670157A (en) * 1995-12-11 1997-09-23 Nestec Ltd. Method for reducing and controlling immunoglobulin concentrations
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
AU9625498A (en) * 1997-09-16 1999-04-05 Societe Des Produits Nestle S.A. Organ specific nutrition
CA2331921A1 (en) * 1998-06-24 1999-12-29 Boyce Thompson Institute For Plant Research, Inc. A novel invertebrate intestinal mucin cdna and related products and methods
EP1034704A1 (en) * 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
EP1222275A2 (en) * 1999-10-22 2002-07-17 The Board of Regents of the University of Nebraska Serum amyloid a isoform from colostrum

Also Published As

Publication number Publication date
DE60118888T3 (de) 2010-09-23
HUP0204439A2 (hu) 2003-04-28
NO20023640D0 (no) 2002-07-31
JP2003533436A (ja) 2003-11-11
DZ3298A1 (fr) 2001-08-09
AU4056401A (en) 2001-08-14
HRP20020647A2 (en) 2004-12-31
HUP0204439A3 (en) 2004-12-28
MXPA02007491A (es) 2002-12-13
DE60118888T2 (de) 2007-01-18
WO2001056405A3 (en) 2002-01-24
EP1255452B2 (en) 2010-03-03
PL357078A1 (en) 2004-07-12
CZ20022978A3 (cs) 2003-02-12
ES2261383T5 (es) 2010-06-18
ATE323422T1 (de) 2006-05-15
CN1434681A (zh) 2003-08-06
IL150977A0 (en) 2003-02-12
CN1434681B (zh) 2010-12-08
WO2001056405A2 (en) 2001-08-09
BG106967A (bg) 2003-04-30
BRPI0108096B1 (pt) 2017-05-09
NZ520605A (en) 2004-06-25
NO20023640L (no) 2002-09-19
EP1255452A2 (en) 2002-11-13
MA25656A1 (fr) 2002-12-31
CA2399063A1 (en) 2001-08-09
IL150977A (en) 2005-09-25
SK11212002A3 (sk) 2003-01-09
DE60118888D1 (de) 2006-05-24
AU784137B2 (en) 2006-02-09
EP1255452B1 (en) 2006-04-19
ES2261383T3 (es) 2010-06-14
CA2399063C (en) 2014-01-28

Similar Documents

Publication Publication Date Title
BR9710768A (pt) Composto composi-Æo e processos para tratamento de infec-{es bacterianas em um mamifero hospedeiro com necessidade de tal tratamento e para prepara-Æo de 6-0-metileritromicina forma i
TW200503708A (en) Gyrase inhibitors and uses thereof
IL172773A (en) Formulations for the treatment of arthritis conditions
PT721449E (pt) Inibidores da producao da proteina beta-amiloide
BRPI0510761A (pt) métodos de tratar um paciente afligido com pelo menos uma enfermidade e de reduzir ou eliminar rugas
DE602004021644D1 (de) Gyraseinhibitoren und deren verwendungen
MY138708A (en) Biaryloxymethylarenecarboxylic acids
BR0015698A (pt) Composições e métodos para tratamento de doenças alérgicas
BRPI0408882A (pt) composições contendo lactulose para tratamento de infecções por rotavìrus
BR0209128A (pt) Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
EP1178796A4 (en) AMINOIMIDAZOLE CARBOXAMIDE SALTS USEFUL IN THE PREVENTION AND TREATMENT OF LIVER DISEASE
BRPI0413404A (pt) composições farmacêuticas, métodos de tratamento ou prevenção de disfunções cardìacas, métodos de aumento da função cardìaca e método de identificação de inibidor de mif
BRPI0409609A (pt) mediadores do transporte reverso de colesterol para o tratamento da hipercolesterolemia
BR0108096A (pt) Método para manter ou melhorar a sìntese de mucinas
ES2096988T3 (es) Organopolisiloxanos que contienen grupos hidrofilos.
IL113940A (en) Synthetic peptides which are elastase inhibitors and pharmaceutical compositions for the treatment of neutrophil associated inflammatory disease containing said inhibitors
BRPI0414139A (pt) métodos e composições para tratar infecções por herpes
WO2003087325A3 (en) Methods and compositions for preventing and treating microbial infections
BR0006301A (pt) Macrólidos antibacterianos e pró-cinéticos
YU58102A (sh) Postupak za održavanje ili poboljšanje sinteze mucina
BR0210063A (pt) Composição estável e uso da mesma
BRPI0519023A2 (pt) composiÇço farmacÊutica contendo pelo menos um derivado de dolastatina 10
MX2020010425A (es) Composicion isotopicamente modificada y sus usos terapeuticos.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ART .8O COMBINADO COM ART. 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23L 33/12 (2016.01)